Thomas, Mayer & Associés (TMA) advised the biotech firm O&O mdc, an engineering company in ophthalmic medical devices, specialising in Intraoculair Lenses(IOL) and viscoelastic manufacturing, research into new technologies and project development, in the sale of its business to He Vision Group, 何氏眼保健体系, a group of companies specialized in comprehensive eye care system including eye specialists hospital, vision centres, university, research industry centre.
Acquisition of the Anglo-Italian Biotech O&O MDC by the Chinese Group
Cookies are used on this website to improve the user experience and to ensure the efficient functioning of the website.
By using this website, you agree to the use of these cookies please read the Cookies page.
- Recent News: Warshaw Burstein Recognized by Best Lawyers In America® 2025 as Best Law Firm, Tier 1 for Family Law in New York City
- Recent News: Chambers Recognizes Warshaw Burstein for Its Real Estate and Trusts and Estates Practice Groups
- Recent News: The Title IX Insider: Thoughts on the Anticipated Rule, Generative AI in the Classroom, Relevant Case Law, and More
- Recent News: The Reciprocal Enforcement of Judgments in Civil and Commercial Matters between Hong Kong and Mainland China
- Recent News: James A. Wolff Featured Panelist at LA Tech Week Event